3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

U.S. AIDS groups battle over federal funding

AIDS/HIVAug 10, 06

The bill would mandate that three-fourths of the funds from the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, the nation’s largest HIV-specific federal grant program, be used for medical services.

Opponents say the mandate would force them to cut non-medical services they consider critical for overall patient care.

Designed to fill gaps in local funding, the Ryan White program has never in its 16-year history included a broad prescription for how money should be spent.

Another divisive proposal on the table includes revamping the formula that directs money from the program in a way that could reduce funding to such historic hot spots like San Francisco and New York City. Those seeking change want more money for rural areas and emerging AIDS centers like Oakland, California.

The Ryan White program, which was named for the boy who got the disease from a blood transfusion and helped raise mainstream awareness, provides care for tens of thousands of patients with no insurance or inadequate coverage and has a budget this year of just under $2.1 billion.

The Enzi-Kennedy legislation is stalled in Congress. Congress must reauthorize the program every five years and its next authorization is scheduled for next month.

More than 1 million people living in the United States are HIV-positive. Half are not in treatment and a study has suggested that one-fifth of them do not have insurance.

AIDS ESTABLISHMENT

One of the more outspoken supporters of the change is AIDS Healthcare Foundation President Michael Weinstein, whose Los Angeles-based group’s mandate over more than two decades has gone from helping people die with dignity to getting them the drugs they need to live.

Weinstein said the Ryan White program needs to change to reflect the 1996 debut of drug cocktails that turned AIDS into a treatable, although still life-threatening, illness.

“If we reauthorize Ryan White without recognizing that, it would be criminal negligence,” he said, adding that it’s time for a shakeout among AIDS service providers who have not kept pace with the fast-moving HIV virus.

“Ryan White is not about maintaining the AIDS establishment. We have to examine all of the sacred cows and we have to slaughter most of them,” he said.

As demand rises amid a lack of significant funding increases for the Ryan White program, Weinstein worries that there won’t be enough money to pay for new, more costly treatments to battle drug-resistant HIV strains.

Janet Weinberg, managing director of development and legislative funding at Gay Men’s Health Crisis, which feeds 350 people a day in New York City and offers help with housing and legal issues, said her group could lose up to $1 million per year at a time when clients are coming in sicker, poorer and with other problems like Hepatitis C or addictions.

“If you don’t know where you’re putting your head at night, are you going to get to the doctor?” she asked.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention
  Cell-associated HIV mucosal transmission: The neglected pathway
  Offering option of initial HIV care at home increases use of ART
  HIV-1 movement across genital tract cells surprisingly enhanced by usurping antibody response
  Indonesia probes Bali tattoo HIV infection report
  Obama raises U.S. goal on fighting AIDS
  New device to test blood can spot cancer cells, HIV on the fly
  Rare HIV-positive individuals shed light on how body could effectively handle infection
  New research examines how HIV infections occur on the molecular level
  An answer to a longstanding question: How HIV infection kills T cells
  Researchers say uncover HIV, insulin resistance link
  Beatrice Hahn and George Shaw, Pioneers in HIV Research, to Join Penn Medicine

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site